Arthur He
Stock Analyst at HC Wainwright & Co.
(0)
# 5089
Out of 5,338 analysts
82
Total ratings
21.15%
Success rate
-38.35%
Average return
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VERA Vera Therapeutics | Assumes: Buy | 75 | 21.25 | 252.94% | 1 | May 5, 2025 | |
ADAG Adagene | Reiterates: Buy | 8 8 | 1.77 | 351.98% | 10 | Apr 3, 2025 | |
ADAP Adaptimmune Therapeu... | Maintains: Buy | 4 3 | 0.26 | 1053.85% | 6 | Apr 1, 2025 | |
BCAB BioAtla | Reiterates: Neutral | n/a | n/a | n/a | 8 | Mar 31, 2025 | |
LVTX LAVA Therapeutics | Reiterates: Neutral | 2 2 | 1.27 | 18.11% | 10 | Mar 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 10 10 | 1.27 | 687.4% | 7 | Mar 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Buy | 7 7 | 0.68 | 855.88% | 3 | Mar 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Strong Buy | 16 20 | 2.6 | 669.23% | 9 | Mar 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | n/a | n/a | n/a | 7 | Jan 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 20 9 | n/a | n/a | 17 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 39 | n/a | n/a | 4 | May 28, 2024 |